
Best of the Week: October 10 – October 16, 2025
Key Takeaways
- Ohio's emergency ban on intoxicating hemp products aims to protect minors and public health, but a restraining order has been issued.
- New York's Cannabis Control Board found Long Island's cannabis ordinances "unreasonably impracticable," limiting municipal barriers to state-licensed businesses.
Our top five cannabis and hemp news this week: Ohio hemp regulation, NY dispensary laws, updates from Florida, and medical cannabis research.
Let’s dive into the top stories shaping the conversation this week. Summaries of each article are listed below.
1. Ohio Enacts Temporary Ban on Intoxicating Hemp Products to Protect Public Health
Though a
As a
2. New York CCB Announces Opinions on Long Island Cannabis Ordinances
The New York State Cannabis Control Board (CCB) deemed Long Island cannabis ordinances "unreasonably impracticable” and shared other state market updates at their monthly public meeting.
The Board announced two advisory opinions which included
In New York State, there are currently 497 legal dispensaries open to conduct businesses in the state.
3. Healer Webinar Discusses New Research on Medical Cannabis for Tourette Syndrome, Neuropathy, and Caregivers
The first part of the coverage of this month’s Healer webinar covered research on Tourette syndrome, chemotherapy-induced neuropathy, and caregiver wellbeing. Dr. Dustin Sulak discussed THC and CBD treatment in adolescents with Tourette syndrome and the effect on tics and quality of life, cannabis formulations' role in reducing symptoms of chemotherapy-induced peripheral neuropathy, and the prevalence of cannabis use among informal caregivers of older adults, especially those with Alzheimer's or dementia.
4. Florida Court Rules Police Can't Use Cannabis Odor for Warrantless Car Searches
A recent ruling by
5. Survey Examines Cannabis Use and GP Discussions in Germany
Cannabis was legalized on April 1, 2024, in Germany, yet questions on the ongoing and future effects on cannabis consumption still remain. In order to further explore harm reduction efforts for cannabis use in Germany, researchers conducted a survey to examine how cannabis consumers talked with their general practitioners (GP) about cannabis consumption. Ultimately, the percentage of those who discussed cannabis consumption was low.
The study, “
Newsletter
Unlock the latest breakthroughs in cannabis science—subscribe now to get expert insights, research, and industry updates delivered to your inbox.